Summary of Significant Accounting Policies (Tables)

12 Months Ended

Feb. 27, 2016

Summary of Significant Accounting Policies

Schedule of revenues

	Year Ended
	February 27, 2016 (52 Weeks)			February 28, 2015 (52 Weeks)		March 1, 2014 (52 Weeks)
Retail Pharmacy segment:
Pharmacy sales	$	18,442,557		$	18,114,768	$	17,239,436
Front end sales		8,238,450			8,232,256		8,168,922
Other revenue		184,924			181,353		118,055
Total Retail Pharmacy segment	$	26,865,931		$	26,528,377	$	25,526,413
Pharmacy Services segment revenue		4,103,513			—		—
Intersegment elimination		(232,787	)		—		—
Total revenue	$	30,736,657		$	26,528,377	$	25,526,413

Schedule of principal classes of products

Product Class	Percentage of Sales
Prescription drugs		69.1	%
Over-the-counter medications and personal care		9.8	%
Health and beauty aids		4.8	%
General merchandise and other		16.3	%

Schedule of impact of the Company's adoption of the ASU on the prior period consolidated balance sheet

	As Previously Reported		Adjustments			As Revised
Other assets	$	286,172	$	(85,827	)	$	200,345
Total assets		8,863,252		(85,827	)		8,777,425
Long-term debt, less current maturities		5,483,415		(85,827	)		5,397,588
Total liabilities		8,806,196		(85,827	)		8,720,369
Total liabilities and stockholders' equity		8,863,252		(85,827	)		8,777,425